|
[Related PubMed/MEDLINE] Total Number of Papers: 45
|
|
|
[Display Entries]
|
|
[Entries Per Page]
|
per page
|
|
Page Control
|
|
Page: of
|
|
|
|
Abbreviation |
: IIEF-EF |
Long Form |
: International Index of Erectile Function |
|
No. |
Year |
Title |
Co-occurring Abbreviation |
1 |
2020 |
Current management strategy of treating patients with erectile dysfunction after radical prostatectomy: a systematic review and meta-analysis. |
CI, ED, IIEF-5, MD, PDE5-Is, RCTs, RP |
2 |
2020 |
Impact of time from diagnosis to treatment on erectile function outcomes after radical prostatectomy. |
AS, EF, PCa, RP |
3 |
2019 |
Comparative efficacy and safety of phosphodiesterase type 5 inhibitors for erectile dysfunction in diabetic men: a Bayesian network meta-analysis of randomized controlled trials. |
ED, GAQ, PDE5-Is, TRAEs |
4 |
2019 |
Efficacy and safety of combination of tadalafil and aspirin versus tadalafil or aspirin alone in patients with vascular erectile dysfunction: a comparative randomized prospective study. |
SEP, VED |
5 |
2019 |
Outcome of buccal mucosa graft urethroplasty: a detailed analysis of success, morbidity and quality of life in a contemporary patient cohort at a referral center. |
BMGU, EQ-5D, ICIQ-MLUTS, QOL, USS PROM |
6 |
2019 |
Penile traction therapy with the new device 'Penimaster PRO' is effective and safe in the stable phase of Peyronie's disease: a controlled multicentre study. |
AEs, NIG, PD, PDQ, PG, PTD, SPL |
7 |
2018 |
Antiplatelet (aspirin) therapy as a new option in the treatment of vasculogenic erectile dysfunction: a prospective randomized double-blind placebo-controlled study. |
SEP, VED |
8 |
2018 |
Effect of Linear Low-Intensity Extracorporeal Shockwave Therapy for Erectile Dysfunction-12-Month Follow-Up of a Randomized, Double-Blinded, Sham-Controlled Study. |
ED, EHS, Li-ESWT |
9 |
2018 |
Long-term Effects of Statins, Blood Pressure-Lowering, and Both on Erectile Function in Persons at Intermediate Risk for Cardiovascular Disease: A Substudy of the Heart Outcomes Prevention Evaluation-3 (HOPE-3) Randomized Controlled Trial. |
HCTZ, HOPE-3, SE |
10 |
2018 |
Penile rehabilitation for postprostatectomy erectile dysfunction. |
CI, Grey Literature Report, PDE5i, RR |
11 |
2017 |
Effects of Low-Intensity Extracorporeal Shockwave Therapy on Erectile Dysfunction: A Systematic Review and Meta-Analysis. |
ED, Li-ESWT |
12 |
2017 |
Efficacy of low-intensity shock wave therapy for erectile dysfunction: A systematic review and meta-analysis. |
LISW, SDM |
13 |
2017 |
Extracorporeal shock wave therapy (ESWT) in urology: a systematic review of outcome in Peyronie's disease, erectile dysfunction and chronic pelvic pain. |
CPP, ED, EHS, ESWT, NIH-CPSI, PD, PDE5i |
14 |
2017 |
Long-term dutasteride therapy in men with benign prostatic hyperplasia alters glucose and lipid profiles and increases severity of erectile dysfunction. |
AMS, AST, BPH, ED, HDL-C, IPSS, LDL-C, LUTS, PSA, TC |
15 |
2017 |
Sildenafil in the Treatment of Erectile Dysfunction in Parkinson's Disease. |
ED, PD |
16 |
2016 |
A review of the efficacy and safety of mirodenafil in the management of erectile dysfunction. |
BPH, ED, LUTS, PDE5-Is |
17 |
2015 |
Finasteride, not tamsulosin, increases severity of erectile dysfunction and decreases testosterone levels in men with benign prostatic hyperplasia. |
5alpha-RIs, BPH, ED, LUTS |
18 |
2015 |
Safety and efficacy of low intensity shockwave (LISW) treatment in patients with erectile dysfunction. |
LISW, LISW, SEP |
19 |
2014 |
Concurrent relations among cigarette smoking status, resting heart rate variability, and erectile response. |
HF, HRV, LF, SD |
20 |
2014 |
Impact of thulium VapoEnucleation of the prostate on erectile function: a prospective analysis of 72 patients at 12-month follow-up. |
IPSS, PVR, QOL, ThuVEP |
21 |
2013 |
A phase 3, placebo controlled study of the safety and efficacy of avanafil for the treatment of erectile dysfunction after nerve sparing radical prostatectomy. |
SEP |
22 |
2013 |
An open-label, long-term evaluation of the safety, efficacy and tolerability of avanafil in male patients with mild to severe erectile dysfunction. |
ED, SEP2 |
23 |
2013 |
Nightly vs on-demand sildenafil for penile rehabilitation after minimally invasive nerve-sparing radical prostatectomy: results of a randomized double-blind trial with placebo. |
EPIC, PDE5, PPPR, RP |
24 |
2011 |
Efficacy and safety of an orodispersible vardenafil formulation for the treatment of erectile dysfunction in elderly men and those with underlying conditions: an integrated analysis of two pivotal trials. |
AEs, ED, ODT, SEP2 |
25 |
2011 |
Efficacy and safety of vardenafil for the treatment of erectile dysfunction in men with metabolic syndrome: results of a randomized, placebo-controlled trial. |
AEs, ED, SEP |
26 |
2011 |
Impact of nasal polyposis on erectile dysfunction. |
BMI, ED, FESS, NP, NPT |
27 |
2011 |
Orally disintegrating vardenafil tablets for the treatment of erectile dysfunction: efficacy, safety, and patient acceptability. |
ED, ODT, SEP |
28 |
2011 |
Relationship between premature ejaculation and depression in Korean males. |
BDI, ED, PE |
29 |
2010 |
Comparison of penile size and erectile function after high-intensity focused ultrasound and targeted cryoablation for localized prostate cancer: a prospective pilot study. |
ED, HIFU, TCAP |
30 |
2010 |
Comparison of the differences in circadian autonomic function in hyperlipidemic men with and without erectile dysfunction. |
--- |
31 |
2010 |
Lack of awareness of erectile dysfunction in many men with risk factors for erectile dysfunction. |
--- |
32 |
2010 |
The POTENT I randomized trial: efficacy and safety of an orodispersible vardenafil formulation for the treatment of erectile dysfunction. |
ED, ODT |
33 |
2010 |
The POTENT II randomised trial: efficacy and safety of an orodispersible vardenafil formulation for the treatment of erectile dysfunction. |
ED, GAQ, ODT, SEP2, TSS |
34 |
2010 |
Vardenafil improves erectile function in men with erectile dysfunction and associated underlying conditions, irrespective of the use of concomitant medications. |
ED, ITT |
35 |
2009 |
Efficacy and safety of combined oral therapy with tadalafil and alfuzosin: an integrated approach to the management of patients with lower urinary tract symptoms and erectile dysfunction. Preliminary report. |
AB, ED, IPSS, LUTS, PDE5 |
36 |
2009 |
Efficacy and safety of tadalafil taken as needed for the treatment of erectile dysfunction in Asian men: results of an integrated analysis. |
ED, GAQ, IIEF, SEP |
37 |
2009 |
Female Assessment of Male Erectile dysfunction detection scale (FAME): development and validation. |
ED, FAME, SHIM |
38 |
2009 |
Is penile length a factor in treatment of erectile dysfunction with PDE-5 inhibitor? |
ED, PDE5 |
39 |
2008 |
A randomised, placebo-controlled study to assess the efficacy of twice-daily vardenafil in the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia. |
BPH, ED, EF, IPSS, LUTS, PVR, QOL |
40 |
2008 |
Response to treatment with tadalafil in men with erectile dysfunction who reported no successful intercourse attempts at baseline. |
ED, EF, SEP |
41 |
2007 |
Improved spontaneous erectile function in men with mild-to-moderate arteriogenic erectile dysfunction treated with a nightly dose of sildenafil for one year: a randomized trial. |
CI, ED, EF, PSV |
42 |
2007 |
Preserved postoperative penile size correlates well with maintained erectile function after bilateral nerve-sparing radical retropubic prostatectomy. |
BNSRRP |
43 |
2007 |
Vardenafil restores erectile function to normal range in men with erectile dysfunction. |
ED, PDE5 |
44 |
2005 |
Improving the sexual quality of life of couples affected by erectile dysfunction: a double-blind, randomized, placebo-controlled trial of vardenafil. |
ED, LOCF, LS, SE, SEP3 |
45 |
2005 |
Women's sexual function improves when partners are administered vardenafil for erectile dysfunction: a prospective, randomized, double-blind, placebo-controlled trial. |
ED, EQS, FSFI, LOCF, LS |
|